Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)
  4. Volume 25, Issue 1
  5. Article
Volume 25, Issue 1
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Background

The effects of thyroid hormone on patients hospitalized in coronary intensive care units are still controversial.

Objective

We retrospectively examined thyroid hormone levels and their impact on cardiovascular morbidity in patients admitted to coronary intensive care units.

Methods

A total of 208 (Female/Male; 46.6%/53.4%) patients without any history of thyroid disease were enrolled and screened. Patients with specific heart disease and existing thyroid hormone parameters were included in the study. Low triiodothyronine syndrome is characterized by reduced serum total or free T3 (fT3) concentrations in normal free T4 (fT4) and TSH levels.

Results

The common diagnosis of the patients in the coronary care unit is acute coronary syndrome (n = 59, 28.2%) and heart failure (n = 46, 23.3%). Patients were divided into two groups according to left ventricular ejection fraction percentages (LVEF ≤39% LVEF ≥40%). Plasma fT3 levels were significantly correlated with low LVEF (≤39%) ( =0.002). fT3 (r = -0.183, =0.013) and hospitalization etiology (r = -0.161, =0.023) were also the most critical parameters affecting the length of hospitalization.

Conclusion

Low fT3 was associated with reduced ejection fraction and prolonged hospitalization, which may lead to potential morbidities in HF patients and may be useful in risk stratification and treatment strategies.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303287732240201122412
2024-04-23
2025-01-17

  • From This Site

    /content/journals/emiddt/10.2174/0118715303287732240201122412
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BenjaminE.J. ViraniS.S. CallawayC.W. ChamberlainA.M. ChangA.R. ChengS. ChiuveS.E. CushmanM. DellingF.N. DeoR. de FerrantiS.D. FergusonJ.F. FornageM. GillespieC. IsasiC.R. JiménezM.C. JordanL.C. JuddS.E. LacklandD. LichtmanJ.H. LisabethL. LiuS. LongeneckerC.T. LutseyP.L. MackeyJ.S. MatcharD.B. MatsushitaK. MussolinoM.E. NasirK. O’FlahertyM. PalaniappanL.P. PandeyA. PandeyD.K. ReevesM.J. RitcheyM.D. RodriguezC.J. RothG.A. RosamondW.D. SampsonU.K.A. SatouG.M. ShahS.H. SpartanoN.L. TirschwellD.L. TsaoC.W. VoeksJ.H. WilleyJ.Z. WilkinsJ.T. WuJ.H.Y. AlgerH.M. WongS.S. MuntnerP. Heart disease and stroke statistics-2018 update: A report from the American Heart Association.Circulation201813712e67e49210.1161/CIR.0000000000000558 29386200
     [Google Scholar]
  2. XanthakisV. EnserroD.M. MurabitoJ.M. PolakJ.F. WollertK.C. JanuzziJ.L. WangT.J. ToflerG. VasanR.S. Ideal cardiovascular health: Associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study.Circulation2014130191676168310.1161/CIRCULATIONAHA.114.009273 25274000
     [Google Scholar]
  3. PaschouS.A. BletsaE. StampouloglouP.K. TsigkouV. ValatsouA. StefanakiK. KazakouP. SpartalisM. SpartalisE. OikonomouE. SiasosG. Thyroid disorders and cardiovascular manifestations: An update.Endocrine202275367268310.1007/s12020‑022‑02982‑4 35032315
     [Google Scholar]
  4. ChakerL. RazviS. BensenorI.M. AziziF. PearceE.N. PeetersR.P. Hypothyroidism.Nat. Rev. Dis. Primers2022813010.1038/s41572‑022‑00357‑7 35589725
     [Google Scholar]
  5. GiontellaA. LottaL.A. OvertonJ.D. BarasA. SartorioA. MinuzP. GillD. MelanderO. FavaC. Association of thyroid function with blood pressure and cardiovascular disease: A mendelian randomization.J. Pers. Med.20211112130610.3390/jpm11121306 34945778
     [Google Scholar]
  6. MantzouratouP. MalaxianakiE. CerulloD. LavecchiaA.M. PantosC. XinarisC. MourouzisI. Thyroid hormone and heart failure: Charting known pathways for cardiac repair/regeneration.Biomedicines202311397510.3390/biomedicines11030975 36979954
     [Google Scholar]
  7. RivasA.M. PenaC. KopelJ. DennisJ.A. NugentK. Hypertension and hyperthyroidism: Association and pathogenesis.Am. J. Med. Sci.202136113710.1016/j.amjms.2020.08.012 33012487
     [Google Scholar]
  8. VidiliG. DelitalaA. ManettiR. Subclinical hyperthyroidism: The cardiovascular point of view.Eur. Rev. Med. Pharmacol. Sci.20212583264327110.26355/eurrev_202104_25735 33928612
     [Google Scholar]
  9. LiuG. RenM. DuY. ZhaoR. WuY. LiuY. QiL. Effect of thyroid hormone replacement treatment on cardiac diastolic function in adult patients with subclinical hypothyroidism: A meta-analysis.Front. Endocrinol.202314126386110.3389/fendo.2023.1263861 37818087
     [Google Scholar]
  10. KaushikA. AgrawalM. Relationship between subclinical hypothyroidism and the risk of cardiovascular complications.Cureus2023151e3370810.7759/cureus.33708 36788909
     [Google Scholar]
  11. Feldt-RasmussenU. EffraimidisG. BliddalS. KloseM. Consequences of undertreatment of hypothyroidism.Endocrine202484230130810.1007/s12020‑023‑03460‑1 37556077
     [Google Scholar]
  12. CohenB. BentalT. PerlL. Vaknin AssaH. CodnerP. OrvinK. BarkanY.T. LeviA. KornowskiR. PerlL. Hypothyroidism predicts worsened prognosis in patients undergoing percutaneous coronary intervention.Front. Cardiovasc. Med.2022998495210.3389/fcvm.2022.984952 36523371
     [Google Scholar]
  13. GilaniN. WangK. MuncanA. PeterJ. AnS. BhattiS. PandyaK. ZhangY. TangY.D. GerdesA.M. StoutR.F. OjamaaK. Triiodothyronine maintains cardiac transverse-tubule structure and function.J. Mol. Cell. Cardiol.202116011410.1016/j.yjmcc.2021.06.010 34175303
     [Google Scholar]
  14. FliersE. BoelenA. An update on non-thyroidal illness syndrome.J. Endocrinol. Invest.20214481597160710.1007/s40618‑020‑01482‑4 33320308
     [Google Scholar]
  15. ZhouP. HuangLY. ZhaiM. HuangY. ZhuangXF. LiuHH. ZhangYH. ZhangJ. Clinical features and prognosis of patients hospitalized with heart failure and low T3 syndrome.Zhonghua Nei Ke Za Zhi202362552653110.3760/cma.j.cn112138‑20230210‑00078
     [Google Scholar]
  16. ShahR. OrlovS. ParéG. GersteinH.C. Thyroid dysfunction and cardiovascular events in patients with dysglycemia.Can. J. Diabetes202347325726210.1016/j.jcjd.2023.01.007 36858924
     [Google Scholar]
  17. TriggianiV. CittadiniA. LiscoG. Effect of levothyroxine replacement therapy in patients with subclinical hypothyroidism and chronic heart failure: A systematic review.Front. Endocrinol.202213101364110.3389/fendo.2022.1013641 36457560
     [Google Scholar]
  18. ZhangX. ChenL. ShengJ. LiC. HeY. HanW. The association of autoantibodies in hyperthyroid heart disease combined with pulmonary hypertension.Int. J. Endocrinol.201920191810.1155/2019/9325289 31885565
     [Google Scholar]
  19. klabundeRE. Cardiovascular Physiology ConceptsLippin-cott Williams & WilkinsPhiladelphia20114159
     [Google Scholar]
  20. RazviS. JabbarA. PingitoreA. DanziS. BiondiB. KleinI. PeetersR. ZamanA. IervasiG. Thyroid hormones and cardiovascular function and diseases.J. Am. Coll. Cardiol.201871161781179610.1016/j.jacc.2018.02.045 29673469
     [Google Scholar]
  21. DinizG.P. TakanoA.P.C. BrunetoE. da SilvaF.G. NunesM.T. Barreto-ChavesM.L.M. New insight into the mechanisms associated with the rapid effect of T3 on AT1R expression.J. Mol. Endocrinol.2012491112010.1530/JME‑11‑0141 22525353
     [Google Scholar]
  22. ChenS. WohlfordG.F. Vecchie’A. CarboneS. YavuzS. Van TassellB. AbbateA. CeliF.S. Acute effects of liothyronine administration on cardiovascular system and energy metabolism in healthy volunteers.Front. Endocrinol.20221384353910.3389/fendo.2022.843539 35295986
     [Google Scholar]
  23. ColletJ.P. ThieleH. BarbatoE. BarthélémyO. BauersachsJ. BhattD.L. DendaleP. DorobantuM. EdvardsenT. FolliguetT. GaleC.P. GilardM. JobsA. JüniP. LambrinouE. LewisB.S. MehilliJ. MeligaE. MerkelyB. MuellerC. RoffiM. RuttenF.H. SibbingD. SiontisG.C.M. KastratiA. MamasM.A. AboyansV. AngiolilloD.J. BuenoH. BugiardiniR. ByrneR.A. CastellettiS. ChieffoA. CornelissenV. CreaF. DelgadoV. DrexelH. GierlotkaM. HalvorsenS. HaugaaK.H. JankowskaE.A. KatusH.A. KinnairdT. KluinJ. KunadianV. LandmesserU. LeclercqC. LettinoM. MeinilaL. MylotteD. NdrepepaG. OmerovicE. PedrettiR.F.E. PetersenS.E. PetronioA.S. PontoneG. PopescuB.A. PotparaT. RayK.K. LucianoF. RichterD.J. ShlyakhtoE. SimpsonI.A. Sousa-UvaM. StoreyR.F. TouyzR.M. ValgimigliM. VranckxP. YehR.W. BarbatoE. BarthélémyO. BauersachsJ. BhattD.L. DendaleP. DorobantuM. EdvardsenT. FolliguetT. GaleC.P. GilardM. JobsA. JüniP. LambrinouE. LewisB.S. MehilliJ. MeligaE. MerkelyB. MuellerC. RoffiM. RuttenF.H. SibbingD. SiontisG.C.M. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.Eur. Heart J.202142141289136710.1093/eurheartj/ehaa575 32860058
     [Google Scholar]
  24. WheltonP.K. CareyR.M. AronowW.S. CaseyD.E.Jr CollinsK.J. Dennison HimmelfarbC. DePalmaS.M. GiddingS. JamersonK.A. JonesD.W. MacLaughlinE.J. MuntnerP. OvbiageleB. SmithS.C.Jr SpencerC.C. StaffordR.S. TalerS.J. ThomasR.J. WilliamsK.A.Sr WilliamsonJ.D. WrightJ.T.Jr 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/] ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A Report of the American college of cardiology/american heart association task force on clinical practice guidelines.Hypertension2018716e13e11510.1161/HYP.0000000000000065 29133356
     [Google Scholar]
  25. MitchellC. RahkoP.S. BlauwetL.A. CanadayB. FinstuenJ.A. FosterM.C. HortonK. OgunyankinK.O. PalmaR.A. VelazquezE.J. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: Recommendations from the american society of echocardiography.J. Am. Soc. Echocardiogr.201932116410.1016/j.echo.2018.06.004 30282592
     [Google Scholar]
  26. PandayP. Arcia FranchiniA.P. IskanderB. AnwerF. OliveriF. KakargiasF. HamidP. Subclinical hypothyroidism in geriatric population and its association with heart failure.Cureus2021134e1429610.7759/cureus.14296 33968510
     [Google Scholar]
  27. YuanD. ZhangC. JiaS. LiuY. JiangL. XuL. ZhangY. XuJ. XuB. HuiR. GaoR. GaoZ. SongL. YuanJ. Predictive value of free triiodothyronine (FT3) to free thyroxine (FT4) ratio in long-term outcomes of euthyroid patients with three-vessel coronary artery disease.Nutr. Metab. Cardiovasc. Dis.202131257958610.1016/j.numecd.2020.10.011 33250369
     [Google Scholar]
  28. ZhaoX. ZhangR. JiangH. LiuK. MaC. BaiM. AnT. YaoY. WangX. WangM. LiY. ZhangY. ZhangJ. Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure.BMC Endocr. Disord.202121114010.1186/s12902‑021‑00801‑x 34215247
     [Google Scholar]
  29. PingitoreA. LandiP. TaddeiM.C. RipoliA. L’AbbateA. IervasiG. Triiodothyronine levels for risk stratification of patients with chronic heart failure.Am. J. Med.2005118213213610.1016/j.amjmed.2004.07.052 15694896
     [Google Scholar]
  30. IervasiG. PingitoreA. LandiP. RacitiM. RipoliA. ScarlattiniM. L’AbbateA. DonatoL. Low-T3 syndrome.Circulation2003107570871310.1161/01.CIR.0000048124.64204.3F 12578873
     [Google Scholar]
  31. RahamimE. NachmanD. YagelO. YarkoniM. Elbaz-GreenerG. AmirO. AslehR. Contemporary pillars of heart failure with reduced ejection fraction medical therapy.J. Clin. Med.20211019440910.3390/jcm10194409 34640427
     [Google Scholar]
  32. BozkurtB. NairA.P. MisraA. ScottC.Z. MaharJ.H. FedsonS. Neprilysin inhibitors in heart failure.JACC Basic Transl. Sci.2023818810510.1016/j.jacbts.2022.05.010 36777165
     [Google Scholar]
  33. MohamudM.A. İbrahimİ.G. AhmedS.A. KarataşM. JeeleM.O.O. Prevalence of thyroid dysfunction among patients with heart failure at a tertiary hospital in Mogadishu, Somalia.Int. J. Gen. Med.2022156335633910.2147/IJGM.S371697 35924177
     [Google Scholar]
  34. HamiltonM.A. StevensonL.W. LuuM. WaldenJ.A. Altered thyroid hormone metabolism in advanced heart failure.J. Am. Coll. Cardiol.1990161919510.1016/0735‑1097(90)90462‑X 2358611
     [Google Scholar]
  35. OpasichC. PaciniF. AmbrosinoN. RiccardiP.G. FeboO. FerrariR. CobelliF. TavazziL. Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure.Eur. Heart J.199617121860186610.1093/oxfordjournals.eurheartj.a014804 8960429
     [Google Scholar]
  36. PsirropoulosD. LefkosN. BoudonasG. EfthimiadisA. VogasV. KeskilidisC. TsapasG. Heart failure accompanied by sick euthyroid syndrome and exercise training.Curr. Opin. Cardiol.200217326627010.1097/00001573‑200205000‑00009 12015476
     [Google Scholar]
  37. KozdagG. UralD. VuralA. AgacdikenA. KahramanG. SahinT. UralE. KomsuogluB. Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy.Eur. J. Heart Fail.20057111311810.1016/j.ejheart.2004.04.016 15642542
     [Google Scholar]
  38. NägeleM.P. BarthelmesJ. KreysingL. HaiderT. NebunuD. RuschitzkaF. SudanoI. FlammerA.J. Endocrine hormone imbalance in heart failure with reduced ejection fraction: A cross‐sectional study.Health Sci. Rep.202256e88010.1002/hsr2.880 36320653
     [Google Scholar]
  39. LiuC. XinZ. HuaL. Lower free triiodothyronine levels are associated with higher all-cause and cardiovascular mortality in people with diabetes-NHANES 2007-2012.Diabetes Res. Clin. Pract.202320211081110.1016/j.diabres.2023.110811 37391035
     [Google Scholar]
  40. SatoY. YoshihisaA. KimishimaY. KikoT. KannoY. YokokawaT. AbeS. MisakaT. SatoT. OikawaM. KobayashiA. YamakiT. KuniiH. NakazatoK. TakeishiY. Low T3 syndrome is associated with high mortality in hospitalized patients with heart failure.J. Card. Fail.201925319520310.1016/j.cardfail.2019.01.007 30682427
     [Google Scholar]
  41. ShiC. BaoY. ChenX. TianL. The effectiveness of thyroid hormone replacement therapy on heart failure and low-triiodothyronine syndrome: An updated systematic review and meta-analysis of randomized controlled trials.Endocr. Pract.202228111178118610.1016/j.eprac.2022.07.004 35850449
     [Google Scholar]
/content/journals/emiddt/10.2174/0118715303287732240201122412
Loading
Is Low-free Triiodothyronine (fT3) Associated with Increased Morbidity in Patients Admitted to Coronary Care Units?
Endocr Metab Immune Disord Drug Targets 25, 57 (2025); https://doi.org/10.2174/0118715303287732240201122412
/content/journals/emiddt/10.2174/0118715303287732240201122412
/content/journals/emiddt/10.2174/0118715303287732240201122412
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Acute coronary syndrome; coronary care unit; euthyroid sick syndrome; heart failure; patients; ventricular ejection fraction percentages

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test